CN103652199A - Liver-protecting schisandra chinensis tea - Google Patents
Liver-protecting schisandra chinensis tea Download PDFInfo
- Publication number
- CN103652199A CN103652199A CN201310683512.8A CN201310683512A CN103652199A CN 103652199 A CN103652199 A CN 103652199A CN 201310683512 A CN201310683512 A CN 201310683512A CN 103652199 A CN103652199 A CN 103652199A
- Authority
- CN
- China
- Prior art keywords
- liver
- fruit
- chinese magnoliavine
- tea
- protecting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 240000006079 Schisandra chinensis Species 0.000 title claims abstract description 29
- 244000269722 Thea sinensis Species 0.000 title claims abstract 9
- 235000008422 Schisandra chinensis Nutrition 0.000 title abstract 3
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 12
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 12
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 12
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 12
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 12
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 12
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 12
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 12
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 12
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 12
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 12
- 241000222336 Ganoderma Species 0.000 claims abstract description 12
- 235000013399 edible fruits Nutrition 0.000 claims description 26
- 241000233866 Fungi Species 0.000 claims description 22
- 241000723353 Chrysanthemum Species 0.000 claims description 11
- 241001092040 Crataegus Species 0.000 claims description 11
- 244000241838 Lycium barbarum Species 0.000 claims description 11
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 11
- 210000004185 liver Anatomy 0.000 abstract description 8
- 208000019423 liver disease Diseases 0.000 abstract description 6
- 239000002994 raw material Substances 0.000 abstract description 4
- 230000036039 immunity Effects 0.000 abstract description 3
- 230000000694 effects Effects 0.000 abstract 2
- 244000028550 Auricularia auricula Species 0.000 abstract 1
- 235000000023 Auricularia auricula Nutrition 0.000 abstract 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 241001289529 Fallopia multiflora Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017784 Mespilus germanica Nutrition 0.000 abstract 1
- 244000182216 Mimusops elengi Species 0.000 abstract 1
- 235000000560 Mimusops elengi Nutrition 0.000 abstract 1
- 241000908178 Tremella fuciformis Species 0.000 abstract 1
- 235000007837 Vangueria infausta Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 241001122767 Theaceae Species 0.000 description 12
- 208000006454 hepatitis Diseases 0.000 description 7
- 208000002672 hepatitis B Diseases 0.000 description 6
- 231100000283 hepatitis Toxicity 0.000 description 5
- 208000019425 cirrhosis of liver Diseases 0.000 description 4
- 206010016654 Fibrosis Diseases 0.000 description 3
- 230000007882 cirrhosis Effects 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 206010008909 Chronic Hepatitis Diseases 0.000 description 2
- 206010019799 Hepatitis viral Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 1
- 208000000419 Chronic Hepatitis B Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 206010018092 Generalised oedema Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010073069 Hepatic cancer Diseases 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010041519 Spider naevus Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 208000024783 anasarca Diseases 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to the technical field of healthcare tea and in particular relates to liver-protecting schisandra chinensis tea. The tea is prepared from the following raw materials: 10-15 g of chrysanthemum, 10-15 g of liquorice, 3-8 g of medlar, 3-5 g of lucid ganoderma, 10-15 g of prepared polygonum multiflorum, 4-8 g of hawthorn, 3-6 g of auricularia auricula, 3-6 g of tremella fuciformis and 3-6 g of schisandra chinensis. The raw materials have the effects of clearing heat, removing toxic materials, protecting the liver and reducing the pressure; the tea has the effects of improving body immunity and effectively prolonging the life of patients with liver diseases.
Description
Technical field
The present invention relates to health tea technique field, relate in particular to a kind of fruit of Chinese magnoliavine liver-protecting tea.
Background technology
Hepatopathy refers to the pathology that occurs in liver.Comprise hepatitis B, hepatitis A, the third liver, cirrhosis, fatization, liver cancer, alcoholic liver etc. hepatic diseases.Be the great disease of a kind of common harmfulness, should take active prevention as main.Common hepatopathy has hepatitis, cirrhosis, hepatapostema, primary carcinoma of liver etc., hepatitis mainly be take chronic hepatitis as main, by teiology, is divided into chronic viral hepatitis, oneself immunity hepatitis, drug toxicity hepatitis, genetic disease and other agnogenic chronic hepatitis.And virus hepatitis is the most common with hepatitis B, hepatitis B is a kind of pandemic infection disease, the number that hepatitis B surface antigen is carried in the whole world is according to statistics over 2.8 hundred million, China is the district occurred frequently of hepatitis B, chronic hepatitis B approximately 3,000 ten thousand people that have at present existing disease, annual domesticly die from liver cirrhosis due to hbv person have 400,000 people.The performance of hepatopathy is that very obscure, the most outstanding symptom is exactly lassitude and weak and do not feel like eating.Common sympton has distending pain or discomfort, feels sick, detest greasy, turgor or have jaundice after food, dry, defecate dry or half congealed, urine Huang, or have low fever, dizzy tinnitus, sallow complexion is simple and unadorned etc.If cirrhosis, outside the clinical manifestation apart from hepatitis, also has ascites, stomach wall blood vessel is outstanding, anasarca, and oliguria, liver palms, spider angioma, severe patient also may massive haemorrhage.For discovery hepatopathy as far as possible early, do in time and check it is very important, occurring oneself has above-mentioned situation, the inspection Hepatitis B virus of should first going to the hospital, liver function, liver B ultrasonic etc.A kind of fruit of Chinese magnoliavine liver-protecting tea of visible invention, drinks at any time, for modern, is a problem demanding prompt solution.
Summary of the invention
The object of the invention is to overcome above-mentioned technical defect, provide a kind of can be easy to carry, the fruit of Chinese magnoliavine liver-protecting tea of drinking at any time.
A fruit of Chinese magnoliavine liver-protecting tea, is prepared from by following component: chrysanthemum 10-15g Radix Glycyrrhizae 10-15g matrimony vine 3-8g glossy ganoderma 3-5g RADIX POLYGONI MULTIFLORI PREPARATA 10-15g hawthorn 4-8g black fungus 3-6g white fungus 3-6g fruit of Chinese magnoliavine 3-6g.
Fruit of Chinese magnoliavine liver-protecting tea, is prepared from by following component: chrysanthemum 10g Radix Glycyrrhizae 10g matrimony vine 3g glossy ganoderma 3g RADIX POLYGONI MULTIFLORI PREPARATA 10g hawthorn 4g black fungus 3g white fungus 3g fruit of Chinese magnoliavine 3g.
Fruit of Chinese magnoliavine liver-protecting tea, is prepared from by following component: chrysanthemum 15g Radix Glycyrrhizae 15g matrimony vine 8g glossy ganoderma 5g RADIX POLYGONI MULTIFLORI PREPARATA 15g hawthorn 8g black fungus 6g white fungus 6g fruit of Chinese magnoliavine 6g.
Fruit of Chinese magnoliavine liver-protecting tea, is prepared from by following component: chrysanthemum 13g Radix Glycyrrhizae 13g matrimony vine 5g glossy ganoderma 4g RADIX POLYGONI MULTIFLORI PREPARATA 13g hawthorn 7g black fungus 5g white fungus 5g fruit of Chinese magnoliavine 5g.
Above-mentioned raw materials, according to proportioning, is rinsed with hot water, then puts into cup, add the hot water of 875-85 degree, every two days 1 dose, 15 days courses for the treatment of.
Beneficial effect of the present invention: above-mentioned raw materials can heat-clearing, and toxin expelling, protects the liver step-down.Improve the immunity of health, effectively increased liver patient's life-span.
The specific embodiment
Below by specific embodiment, further illustrate technical scheme of the present invention, but content of the present invention is not limited with specific embodiment.
Embodiment 1
Fruit of Chinese magnoliavine liver-protecting tea, is prepared from by following component: chrysanthemum 10g Radix Glycyrrhizae 10g matrimony vine 3g glossy ganoderma 3g RADIX POLYGONI MULTIFLORI PREPARATA 10g hawthorn 4g black fungus 3g white fungus 3g fruit of Chinese magnoliavine 3g.
Embodiment 2
Fruit of Chinese magnoliavine liver-protecting tea, is prepared from by following component: chrysanthemum 15g Radix Glycyrrhizae 15g matrimony vine 8g glossy ganoderma 5g RADIX POLYGONI MULTIFLORI PREPARATA 15g hawthorn 8g black fungus 6g white fungus 6g fruit of Chinese magnoliavine 6g.
Embodiment 3
Fruit of Chinese magnoliavine liver-protecting tea, is prepared from by following component: chrysanthemum 13g Radix Glycyrrhizae 13g matrimony vine 5g glossy ganoderma 4g RADIX POLYGONI MULTIFLORI PREPARATA 13g hawthorn 7g black fungus 5g white fungus 5g fruit of Chinese magnoliavine 5g.
Claims (4)
1. a fruit of Chinese magnoliavine liver-protecting tea, is characterized in that: by following component, be prepared from: chrysanthemum 10-15g Radix Glycyrrhizae 10-15g matrimony vine 3-8g glossy ganoderma 3-5g RADIX POLYGONI MULTIFLORI PREPARATA 10-15g hawthorn 4-8g black fungus 3-6g white fungus 3-6g fruit of Chinese magnoliavine 3-6g.
2. fruit of Chinese magnoliavine liver-protecting tea as claimed in claim 1, is characterized in that: by following component, be prepared from: chrysanthemum 10g Radix Glycyrrhizae 10g matrimony vine 3g glossy ganoderma 3g RADIX POLYGONI MULTIFLORI PREPARATA 10g hawthorn 4g black fungus 3g white fungus 3g fruit of Chinese magnoliavine 3g.
3. fruit of Chinese magnoliavine liver-protecting tea as claimed in claim 1, is characterized in that: by following component, be prepared from: chrysanthemum 15g Radix Glycyrrhizae 15g matrimony vine 8g glossy ganoderma 5g RADIX POLYGONI MULTIFLORI PREPARATA 15g hawthorn 8g black fungus 6g white fungus 6g fruit of Chinese magnoliavine 6g.
4. fruit of Chinese magnoliavine liver-protecting tea as claimed in claim 1, is characterized in that: by following component, be prepared from: chrysanthemum 13g Radix Glycyrrhizae 13g matrimony vine 5g glossy ganoderma 4g RADIX POLYGONI MULTIFLORI PREPARATA 13g hawthorn 7g black fungus 5g white fungus 5g fruit of Chinese magnoliavine 5g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310683512.8A CN103652199B (en) | 2013-12-13 | 2013-12-13 | A kind of fruit of Chinese magnoliavine liver-protecting tea |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310683512.8A CN103652199B (en) | 2013-12-13 | 2013-12-13 | A kind of fruit of Chinese magnoliavine liver-protecting tea |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103652199A true CN103652199A (en) | 2014-03-26 |
| CN103652199B CN103652199B (en) | 2015-09-30 |
Family
ID=50291917
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310683512.8A Expired - Fee Related CN103652199B (en) | 2013-12-13 | 2013-12-13 | A kind of fruit of Chinese magnoliavine liver-protecting tea |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103652199B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104997028A (en) * | 2015-07-30 | 2015-10-28 | 刘大仟 | Food therapy formula for alleviating mental pressure and preparation method of food therapy formula |
| CN109315557A (en) * | 2018-11-16 | 2019-02-12 | 万顺宝(肇庆)实业有限公司 | A kind of miracle fruit compound tea and preparation method thereof with liver protecting |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1109276A (en) * | 1994-12-20 | 1995-10-04 | 王立君 | Liver nourishing tea |
| CN1394501A (en) * | 2001-07-11 | 2003-02-05 | 徐青 | Chinese medicine composite health-care tea and its preparation method |
| CN101204183A (en) * | 2006-12-20 | 2008-06-25 | 抚顺市艺宝参茸药材有限责任公司 | Schisandra health care tea and manufacture method thereof |
| CN101889617A (en) * | 2010-06-13 | 2010-11-24 | 王德荣 | Liver-nourishing and eyesight-improving tea and preparation method thereof |
| CN102084923A (en) * | 2009-12-07 | 2011-06-08 | 成都百康药业有限责任公司 | Method for preparing medlar and Chinese magnoliavine fruit tea |
-
2013
- 2013-12-13 CN CN201310683512.8A patent/CN103652199B/en not_active Expired - Fee Related
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1109276A (en) * | 1994-12-20 | 1995-10-04 | 王立君 | Liver nourishing tea |
| CN1394501A (en) * | 2001-07-11 | 2003-02-05 | 徐青 | Chinese medicine composite health-care tea and its preparation method |
| CN101204183A (en) * | 2006-12-20 | 2008-06-25 | 抚顺市艺宝参茸药材有限责任公司 | Schisandra health care tea and manufacture method thereof |
| CN102084923A (en) * | 2009-12-07 | 2011-06-08 | 成都百康药业有限责任公司 | Method for preparing medlar and Chinese magnoliavine fruit tea |
| CN101889617A (en) * | 2010-06-13 | 2010-11-24 | 王德荣 | Liver-nourishing and eyesight-improving tea and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 孟庆恒等: "食用菌的药用价值", 《生物学通报》 * |
| 张影等: "北五味子复合保健茶的研制", 《黑龙江农业科学》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104997028A (en) * | 2015-07-30 | 2015-10-28 | 刘大仟 | Food therapy formula for alleviating mental pressure and preparation method of food therapy formula |
| CN109315557A (en) * | 2018-11-16 | 2019-02-12 | 万顺宝(肇庆)实业有限公司 | A kind of miracle fruit compound tea and preparation method thereof with liver protecting |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103652199B (en) | 2015-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105250997A (en) | Composition used for dispelling effects of alcohol and protecting liver, and preparation method thereof | |
| CN103652199B (en) | A kind of fruit of Chinese magnoliavine liver-protecting tea | |
| US11000569B2 (en) | Medicament for use in treating fatty liver, hepatitis and cirrhosis | |
| CN103652192A (en) | Liver protection tea | |
| Liu et al. | The Chinese medicine Kuan-Sin-Yin improves liver function in patients with chronic hepatitis C: A randomised and placebo-controlled trial | |
| CN103638488B (en) | One treats pleuritic Chinese medicine composition | |
| CN103127480A (en) | Drug for curing constipation | |
| CN102406880A (en) | Medicine or healthcare food with anti-fatigue and immunity-enhancing effects | |
| CN102973875B (en) | Medicament for strengthening spleen, checking diarrhea and removing food retention for children | |
| CN106615370A (en) | Tea capable of soothing liver and invigorating blood circulation and preparation method thereof | |
| CN103989995A (en) | Pharmaceutical composition for treating fatty liver | |
| CN103768390A (en) | Traditional Chinese medicine effective part composition for treating nasopharynx cancer | |
| CN102836403B (en) | Chinese medicine for treating chronic nephritis by using root of low greenbrier | |
| CN103099841A (en) | Traditional Chinese medicinal composition for treatment of hepatitis | |
| CN107617091A (en) | A kind of Chinese medicine composition for treating cold asthma | |
| CN105832946A (en) | Medicine for treating human cancer and production method thereof | |
| CN106039194A (en) | Composite preparation for treating leucopenia caused by radiotherapy and chemotherapy | |
| CN105412646A (en) | Traditional Chinese medicinal composition for treating exogenous fever and application of traditional Chinese medicinal composition | |
| CN104436093A (en) | Formula of traditional Chinese medicine for treating cough | |
| CN104225232A (en) | Traditional Chinese medicine composition for treating viral myocarditis | |
| CN106474427A (en) | A kind of Chinese medicine composition treating hepatitis C | |
| CN106138224A (en) | One controls parotitic formula | |
| CN103768341A (en) | Traditional Chinese medicine effective part composition for treating primary glaucoma | |
| CN103623276B (en) | A kind of oral preparation of Chinese traditional medicinal for the treatment of hepatitis B | |
| CN106937685A (en) | A kind of blood-nourishing soothing the liver tea and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: GUANGDONG HUABO ENTERPRISE MANAGEMENT CONSULTING C Free format text: FORMER OWNER: JINAN CAVIN BIOTECHNOLOGY CO., LTD. Effective date: 20150818 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent of invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Hu Lichun Inventor before: Chi Zonglei Inventor before: Cang Weigong |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: CHI ZONGLEI ZANG WEIGONG TO: HU LICHUN |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20150818 Address after: 510640 Guangdong city of Guangzhou province Tianhe District gold Yinglu No. 1 was 1106 room two Applicant after: Guangdong Huabo Enterprise Management Consulting Co., Ltd. Address before: 250199, building 389, Huaxin Road, Licheng District, Shandong, Ji'nan 401 Applicant before: JINAN CAVIN BIOTECHNOLOGY CO., LTD. |
|
| ASS | Succession or assignment of patent right |
Owner name: NINGBO JIANGDONG YUPIN TEA TRADING COMPANY Free format text: FORMER OWNER: GUANGDONG HUABO ENTERPRISE MANAGEMENT CONSULTING CO., LTD. Effective date: 20150901 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20150901 Address after: 315046 A2 shop, Jiangdong South Road, Jiangdong District, Zhejiang, Ningbo 145, China Applicant after: JINAN CAVIN BIOLOGICAL SCIENCE & TECHNOLOGY CO., LTD. Address before: 510640 Guangdong city of Guangzhou province Tianhe District gold Yinglu No. 1 was 1106 room two Applicant before: Guangdong Huabo Enterprise Management Consulting Co., Ltd. |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150930 Termination date: 20161213 |